⟵ Back to Search Results

BGB-283-AU-001

Completed

Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors

Beigene Study ID info

BGB-283-AU-001

ClinicalTrials.gov ID info

NCT02610361

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents